Endothelin A receptor drugs for Pulmonary Arterial Hypertension
2 tracked Endothelin A receptor drugs in the Pulmonary Arterial Hypertension race. The class explanation lives on the Endothelin A receptor page; the full indication pipeline across every mechanism is on the Pulmonary Arterial Hypertension page.
1 approved / phase 41 preclinical / unstaged
Head-to-head evidence: Ambrisentan vs F230